← SynDRA
4-Methyl-N-9H-xanthen-9-yl-benzenesulfonamide
SynDRA canonical compound SYN1466204 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | FFAR4 |
|---|
| Mechanism of action | free fatty acid receptor antagonist |
|---|
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- RefChem:912680
- AH 7614
- 4-Methyl-N-(9H-xanthen-9-yl)benzenesulfonamide
- 4-Methyl-N-(9H-xanthen-9-yl)-benzenesulfonamide
- 4-methyl-N-(9H-xanthen-9-yl)benzene-1-sulfonamide
- AH7614
- p-Toluenesulfonamide, N-(xanthen-9-yl)-
- NSC31171
- MFCD00379273
- ChemDiv3_003436
- Oprea1_006107
- Oprea1_382032
- N-xanthyl-p-toluenesulfonamide
- orb1306116
- SCHEMBL19260836
- SCHEMBL29884087
- OZCQEUZTOAAWDK-UHFFFAOYSA-N
- GLXC-05376
- HMS1482M04
- EX-A7154
- BDBM50044874
- NSC-31171
- s9477
- STK325647
- AKOS001663516
- CCG-111864
- IDI1_021346
- AC-36775
- AH-7614?
- HY-19996
- MS-25439
- ST4034127
- [(4-methylphenyl)sulfonyl]xanthen-9-ylamine
- CS-0017905
- AH-7614, >=98% (HPLC)
- G12588
- T22027
- Benzenesulfonamide, 4-methyl-N-(xanthen-9-yl)-
- AG-690/09709049
Look up 4-Methyl-N-9H-xanthen-9-yl-benzenesulfonamide in the interactive SynDRA portal →